Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02157792
Title M6620 First in Human Study
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors EMD Serono Research & Development Institute, Inc.
Indications

Advanced Solid Tumor

lung small cell carcinoma

lung non-small cell carcinoma

triple-receptor negative breast cancer

Therapies

Berzosertib + Irinotecan

Berzosertib + Cisplatin + Gemcitabine

Berzosertib + Cisplatin + Etoposide

Berzosertib + Cisplatin

Berzosertib + Carboplatin + Cisplatin

Berzosertib + Gemcitabine

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.